Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-022226
Filing Date
2024-02-28
Accepted
2024-02-28 17:00:38
Documents
99
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K avir-20231231.htm   iXBRL 10-K 2870893
2 EX-10.1(3) avir-ex10_13.htm EX-10.1(3) 61847
3 EX-10.1(4) avir-ex10_14.htm EX-10.1(4) 61257
4 EX-21.1 avir-ex21_1.htm EX-21.1 6003
5 EX-23.1 avir-ex23_1.htm EX-23.1 4159
6 EX-31.1 avir-ex31_1.htm EX-31.1 16200
7 EX-31.2 avir-ex31_2.htm EX-31.2 16073
8 EX-32.1 avir-ex32_1.htm EX-32.1 9579
9 EX-32.2 avir-ex32_2.htm EX-32.2 9901
10 EX-97.1 avir-ex97_1.htm EX-97.1 34472
11 GRAPHIC img57592461_0.jpg GRAPHIC 58459
12 GRAPHIC img57592461_1.jpg GRAPHIC 48319
13 GRAPHIC img57592461_2.jpg GRAPHIC 74704
14 GRAPHIC img57592461_3.jpg GRAPHIC 44478
15 GRAPHIC img57592461_4.jpg GRAPHIC 116127
16 GRAPHIC img57592461_5.jpg GRAPHIC 274817
17 GRAPHIC img57592461_6.jpg GRAPHIC 22747
18 GRAPHIC img57592461_7.jpg GRAPHIC 30495
19 GRAPHIC img57592461_8.jpg GRAPHIC 117599
20 GRAPHIC img57592461_9.jpg GRAPHIC 39355
21 GRAPHIC img57592461_10.jpg GRAPHIC 57287
22 GRAPHIC img57592461_11.jpg GRAPHIC 72544
23 GRAPHIC img57592461_12.jpg GRAPHIC 32387
24 GRAPHIC img57592461_13.jpg GRAPHIC 139591
25 GRAPHIC img57592461_14.jpg GRAPHIC 56003
  Complete submission text file 0000950170-24-022226.txt   12780308

Data Files

Seq Description Document Type Size
26 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT avir-20231231.xsd EX-101.SCH 1344718
101 EXTRACTED XBRL INSTANCE DOCUMENT avir-20231231_htm.xml XML 1487968
Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110
Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109
Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)

EIN.: 460574869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39661 | Film No.: 24696550
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)